KUS121: Clinical Trials

1 trial of KUS121, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow KUS121: new trials by email Literature Review of KUS121 trials Research Report on KUS121

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)
KUS121 high dose, KUS121 low dose, Sham procedure - Central Retinal Artery Occlusion
Phase 2CompletedKyoto Drug Discovery and Development Co., Ltd.172024-04-162026-02-18

Conditions studied

Retinal Artery Occlusion (1)

Sponsors

Kyoto Drug Discovery and Development Co., Ltd. (1)

Countries

United States (1)

Top investigators

Kunihiro Musashi, MD., Ph.D. (1)